Latest price-to-book ratio
Prelude Therapeutics Price-to-book ratio
Direct answer
Prelude Therapeutics's price-to-book ratio is 2.79x.
The verified market snapshot reports 2.79x.
Bullstory displays the reported value and does not estimate missing data.
Market data checked October 25, 2026.
Get free Prelude Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Price-to-book ratio
- 2.79x
Explore related company data
View Prelude Therapeutics's market capitalizationView Prelude Therapeutics's return on equityView Prelude Therapeutics's dividend yieldView Prelude Therapeutics's 52-week price rangeView Prelude Therapeutics's profit marginView Prelude Therapeutics's debt-to-equity ratioView all Prelude Therapeutics key metricsReturn to Prelude Therapeutics profile